AU2002213119A1 - Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same - Google Patents

Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same

Info

Publication number
AU2002213119A1
AU2002213119A1 AU2002213119A AU1311902A AU2002213119A1 AU 2002213119 A1 AU2002213119 A1 AU 2002213119A1 AU 2002213119 A AU2002213119 A AU 2002213119A AU 1311902 A AU1311902 A AU 1311902A AU 2002213119 A1 AU2002213119 A1 AU 2002213119A1
Authority
AU
Australia
Prior art keywords
tegafur
vinorelbine
uracil
administration
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213119A
Inventor
Jacques Bonneterre
Regine Deportefety
Pierre Fargeot
Pierre Fumoleau
Florence Garet
Pierre Kerbrat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2002213119A1 publication Critical patent/AU2002213119A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
AU2002213119A 2000-10-13 2001-10-11 Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same Abandoned AU2002213119A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24047500P 2000-10-13 2000-10-13
US60240475 2000-10-13
US24580500P 2000-11-03 2000-11-03
US60245805 2000-11-03
PCT/US2001/031796 WO2002030427A1 (en) 2000-10-13 2001-10-11 Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same

Publications (1)

Publication Number Publication Date
AU2002213119A1 true AU2002213119A1 (en) 2002-04-22

Family

ID=26933438

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213119A Abandoned AU2002213119A1 (en) 2000-10-13 2001-10-11 Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same

Country Status (2)

Country Link
AU (1) AU2002213119A1 (en)
WO (1) WO2002030427A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918566B1 (en) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa STABLE PHARMACEUTICAL COMPOSITION OF A WATER SOLUBLE SALT OF VINFLUNINE.

Also Published As

Publication number Publication date
WO2002030427A1 (en) 2002-04-18

Similar Documents

Publication Publication Date Title
HUP0202795A3 (en) Pyrimidine and pyrazine derivatives, pharmaceutical compositions containing them and their use
IL161431A0 (en) beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
AU2002219174A1 (en) Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof
HUP0204410A3 (en) Pyrimidine-4-one derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201633A3 (en) Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof
HUP0303016A3 (en) Xanthine phosphodiesterase v inhibitors, process for their preparation and pharmaceutical compositions containing them and their use
HUP0201122A2 (en) Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them
AU2001278771A1 (en) Carboxylic acid derivatives, process for producing the same and drugs containingthe same as the active ingredient
AU2001284021A1 (en) Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL147744A0 (en) Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
HUP0204550A3 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation and process for its preparation
ZA200109602B (en) Purine derivatives, preparation method and pharmaceutical compositions containing same.
AU2001240001A1 (en) Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
EP1490358A4 (en) 6-(4-substituted-anilino)pyrimidine derivatives, method for the preparation thereof and antiviral pharmaceutical composition comprising the same
HUP0303045A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
AU6038601A (en) Amino acid derivatives and their use as medicines
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU5428700A (en) Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
AU2001258200A1 (en) Synthetic derivatives of lunularic acid, medicaments containing said compounds, method for producing the lunularic acid derivatives and the use thereof
AU2002213119A1 (en) Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and vinorelbine and method of using the same
AU2001296746A1 (en) Oral dosage forms for administration of the combination of tegafur, uracil, folinic acid, and irinotecan and method of using the same
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
HUP0303953A3 (en) Method for preparation of pharmaceutical composition for treating tumors by using tegafur, uracil, folinic acid, and cyclophospamide
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof